US-based medical device manufacturer Life Spine has obtained the US Food & Drug Administration (FDA) approval to market its GHOST 3D-printed titanium spacer systems.

The GHOST 3D-printed titanium spacer systems are designed to integrate porous structure within the endplate surfaces and along the graft window column.

The implants are available in a broad range of footprints and lordotic offerings to facilitate ALIF, PLIF/TLIF and Lateral procedures, in different patient anatomies and pathologies.

GHOST implants are designed to have large graft windows to fuse with bone graft material, along with smooth tapered tip and simplified instrumentation.

They are backed by the company’s AVATAR Percutaneous Screw System, NAUTILUS Spinal Fixation System, CENTERLINE Midline Screw System and ARx Spinal Fixation System.

Life Spine said the GHOST expands its interbody portfolio, which includes PEEK, titanium devices, with 3D-printed titanium spacers.

Life Spine marketing SVP Mariusz Knap said: “We are excited about the expansion of our interbody portfolio to include 3D-printed implants. Our robust offering is one of the broadest in the industry and includes solutions for nearly every procedure and surgeon preference.

“With the PEEK, Titanium, and Expandable interbody product lines, the addition of 3D-Printed Titanium interbodies allows Life Spine to offer physicians alternative solutions to customize their patient’s treatment.”

Life Spine is a medical technology company engaged in designing, developing, manufacturing and commercialising products for the surgical treatment of spinal disorders.

Earlier this year, the medical device company has secured FDA marketing approval for its SImpact SI Joint Fixation System for posterior-oblique approaches.

Life Spine said that SImpact is uniquely designed to enable both direct lateral or the newly approved posterior-oblique procedures, using the same screws and same instrumentation.